Prostate cancer recurring as small‐cell carcinoma with a BRCA2 somatic mutation
IJU Case Reports · 2022-11 · 5 (6) · 489-492
DOI: 10.1002/iju5.12523 ↗Kurz gefasst
Fallbericht in der Zeitschrift IJU Case Reports, online erschienen am 12.08.2022. Verfasst von Ryo Yabusaki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Shizuoka General Hospital Shizuoka Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Small‐cell carcinoma of the prostate has a poor prognosis, and treatment options for the refractory disease are unclear. Case presentation A 68‐year‐old man with prostate cancer was referred to our hospital. He was treated with combined androgen blockade (bicalutamide and degarelix acetate). The disease progressed to castration‐resistant prostate cancer, but with additional treatment, prostate‐specific antigen levels remained below 0.02 ng/mL. However, computed tomography revealed enlarged right inguinal lymph nodes; moreover, his neuron‐specific enolase levels were elevated. Histopathologic analysis of a biopsied lymph node confirmed small‐cell carcinoma. After administering cytotoxic chemotherapy (etoposide plus cisplatin and amrubicin), the patient temporarily improved before relapsing. After genetic testing of the biopsy specimen revealed a BRCA2 deletion, we administered the oral PARP‐2 inhibitor olaparib, which has achieved partial remission for 8 months.
Conclusion
PARP‐2 inhibition may improve the survival of patients with BRCA2 ‐positive small‐cell carcinoma of the prostate.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology Shizuoka General Hospital Shizuoka Japan.
- Department of Oncology Shizuoka General Hospital Shizuoka Japan.
- Department of Pathology Shizuoka General Hospital Shizuoka Japan.
ORCID-Profile: Ryo Yabusaki, Koji Yoshimura
Zitieren
APA
Yabusaki, R., Yoshimura, K., Taku, K., & Suzuki, M. (2022). Prostate cancer recurring as small‐cell carcinoma with a BRCA2 somatic mutation. IJU Case Reports, 5(6), 489-492. https://doi.org/10.1002/iju5.12523
Vancouver
Yabusaki R, Yoshimura K, Taku K, Suzuki M. Prostate cancer recurring as small‐cell carcinoma with a BRCA2 somatic mutation. IJU Case Reports. 2022;5(6):489-492. doi:10.1002/iju5.12523
BibTeX
@article{Yabusaki2022,
author = {Yabusaki, Ryo and Yoshimura, Koji and Taku, Keisei and Suzuki, Makoto},
title = {Prostate cancer recurring as small‐cell carcinoma with a BRCA2 somatic mutation},
journal = {IJU Case Reports},
year = {2022},
volume = {5},
number = {6},
pages = {489--492},
doi = {10.1002/iju5.12523}
}
EUVIMED